| FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets R Saleh, E Elkord Cancer letters 490, 174-185, 2020 | 202 | 2020 |
| T‐cell responses and therapies against SARS‐CoV‐2 infection SM Toor, R Saleh, V Sasidharan Nair, RZ Taha, E Elkord Immunology 162 (1), 30-43, 2021 | 201 | 2021 |
| Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression R Saleh, E Elkord Seminars in cancer biology 65, 13-27, 2020 | 198 | 2020 |
| Treg-mediated acquired resistance to immune checkpoint inhibitors R Saleh, E Elkord Cancer letters 457, 168-179, 2019 | 177 | 2019 |
| Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation A Achuthan, AD Cook, MC Lee, R Saleh, HW Khiew, MWN Chang, ... The Journal of clinical investigation 126 (9), 3453-3466, 2016 | 143 | 2016 |
| Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer R Saleh, RZ Taha, SM Toor, V Sasidharan Nair, K Murshed, M Khawar, ... Cancer Immunology, Immunotherapy 69, 1989-1999, 2020 | 91 | 2020 |
| Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells R Saleh, SM Toor, S Khalaf, E Elkord Vaccines 7 (4), 149, 2019 | 86 | 2019 |
| CCL17 blockade as a therapy for osteoarthritis pain and disease MC Lee, R Saleh, A Achuthan, AJ Fleetwood, I Förster, JA Hamilton, ... Arthritis research & therapy 20, 1-10, 2018 | 78 | 2018 |
| Role of epigenetic modifications in inhibitory immune checkpoints in cancer development and progression R Saleh, SM Toor, V Sasidharan Nair, E Elkord Frontiers in immunology 11, 544793, 2020 | 67 | 2020 |
| PD-L1 blockade by atezolizumab downregulates signaling pathways associated with tumor growth, metastasis, and hypoxia in human triple negative breast cancer R Saleh, RZ Taha, V Sasidharan Nair, NM Alajez, E Elkord Cancers 11 (8), 1050, 2019 | 67 | 2019 |
| Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer V Sasidharan Nair, R Saleh, SM Toor, RZ Taha, AA Ahmed, MA Kurer, ... Clinical epigenetics 12, 1-15, 2020 | 52 | 2020 |
| Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation AD Cook, C Louis, MJ Robinson, R Saleh, MA Sleeman, JA Hamilton Arthritis Research & Therapy 18, 1-15, 2016 | 48 | 2016 |
| TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17 AD Cook, MC Lee, R Saleh, HW Khiew, AD Christensen, A Achuthan, ... JCI insight 3 (6), 2018 | 46 | 2018 |
| Elkord E R Saleh FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic …, 2020 | 36 | 2020 |
| G-CSF receptor blockade ameliorates arthritic pain and disease MC Lee, JA McCubbin, AD Christensen, DP Poole, P Rajasekhar, ... The Journal of Immunology 198 (9), 3565-3575, 2017 | 32 | 2017 |
| Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment V Sasidharan Nair, R Saleh, SM Toor, FS Cyprian, E Elkord Cancer immunology, immunotherapy 70, 2103-2121, 2021 | 27 | 2021 |
| CSF-1 in inflammatory and arthritic pain development R Saleh, MC Lee, SH Khiew, C Louis, AJ Fleetwood, A Achuthan, I Förster, ... The Journal of Immunology 201 (7), 2042-2053, 2018 | 27 | 2018 |
| Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis R Saleh, VS Nair, SM Toor, RZ Taha, K Murshed, M Al-Dhaheri, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 25 | 2020 |
| DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR– myeloid cells, compared with HLA-DR+ antigen … R Saleh, SM Toor, RZ Taha, D Al-Ali, V Sasidharan Nair, E Elkord Epigenetics 15 (12), 1275-1288, 2020 | 21 | 2020 |
| Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential R Saleh, SM Toor, E Elkord Expert Opinion on Therapeutic Targets 24 (12), 1251-1262, 2020 | 18 | 2020 |
